Skip to main content
. 2022 Jul 26;2022:9929038. doi: 10.1155/2022/9929038

Table 1.

Comparisons of the clinical characteristics of patients between transient AKI, persistent AKI, and non-AKI with coronavirus disease 2019.

Characteristic Non-AKI group (59, 55.1) Transient AKI (11, 22.9) Persistent AKI (37, 77.1) P value a
Age (years) 68 (63–75) 73 (67–81) 73 (66–82) 0.097
Male sex 37 (62.7) 6 (54.5) 26 (70.3) 0.578
Body mass index (kg/m2) 22.8 ± 1.9 23.7 ± 1.8 23.7 ± 2.7 0.105
Comorbidity
 Hypertension 37 (62.7) 8 (72.7) 28 (75.7) 0.386
 Cardiovascular disease 12 (20.3) 4 (36.4) 17 (45.9) 0.028
 COPD 12 (20.3) 1 (9.1) 10 (27.0) 0.388
 Diabetes 10 (16.9) 1 (9.1) 11 (29.7) 0.193
 Cerebrovascular disease 6 (10.2) 6 (54.5) 7 (18.9) 0.006
 CKD 0 0 5 (13.5) 0.004
Signs and symptoms
 Cough 51 (86.4) 7 (63.6) 31 (83.8) 0.234
 Fever 46 (78.0) 9 (81.8) 26 (70.3) 0.615
 Dyspnea 47 (79.7) 4 (36.4) 26 (70.3) 0.019
 Muscle ache 38 (64.4) 5 (45.5) 25 (67.6) 0.413
 Fatigue 34 (57.6) 6 (54.5) 21 (56.8) 0.982
 Chest pain 11 (18.6) 1 (9.1) 4 (10.8) 0.478
 Chills 11 (18.6) 1 (9.1) 4 (10.8) 0.478
 Headache 4 (6.8) 1 (9.1) 1 (2.7) 0.582
 Diarrhea 1 (1.7) 0 3 (8.1) 0.204
Chest CT findings
 Multiple mottling and ground glass opacity 56 (94.9) 11 (100.0) 33 (89.2) 0.267
Pneumonia 0.549
 Unilateral pneumonia 1 (1.7) 0 0
 Bilateral pneumonia 58 (98.3) 11 (100.0) 37 (100.0)
Disease classification <0.001
 Severe 30 (50.8) 1 (9.1) 6 (16.2)
 Critical 29 (49.2) 10 (90.9) 31 (83.8)
On ICU admission
 MAP 97 ± 15 94 ± 23 95 ± 21 0.881
 Albumin (g/L) 31.9 ± 3.8 30.5 ± 4.4 31.1 ± 4.6 0.493
 BUN (mmol/L) 6.1 (4.5–8.1) 7.3 (4.9–9.8) 10.0 (6.4–14.0) <0.001
 Uric acid (μmol/L) 189.0 (133.0–229.0) 225.0 (192.0–378.0) 293.0 (184.0–427.5) <0.001
 Potassium (μmol/l) 4.2 (3.8–4.5) 4.3 (4.1–5.0) 4.2 (3.9–4.8) 0.372
 Sodium (mmol/l) 140.0 (137.0–143.0) 138.0 (139.0–144.0) 143.0 (137.0–146.0) 0.095
 Chlorine (mmol/l) 103.0 (100.0–106.0) 103.0 (101.0–109.0) 104.0 (102.0–111.0) 0.097
 Calcium (mmol/L) 2.0 (1.9–2.2) 2.0 (1.9–2.3) 2.0 (1.9–2.0) 0.038
 Phosphate (mmol/L) 0.9 (0.7–1.0) 1.0 (0.7–1.4) 0.9 (0.7–1.1) 0.223
 Magnesium (mmol/L) 0.9 (0.8–1.0) 0.9 (0.9–1.0) 1.0 (0.9–1.1) 0.054
 Cystatin C (mg/L) 1.0 (0.9–1.2) 1.4 (1.1–1.8) 1.4 (1.1–1.9) <0.001
 Hemoglobin (g/L) 114 ± 20 111 ± 19 122 ± 21 0.135
 Platelets (×109/L) 224 (165–276) 189 (65–351) 152 (58–182) <0.001
 C-reactive protein (mg/L) 33.2 (8.7–112.4) 76.0 (11.7–152.6) 92.6 (25.8–151.9) 0.091
Blood gas analysis
 Lactate (mmol/L) 1.2 (0.7–2.3) 1.3 (1.1–3.7) 2.2 (1.5–3.7) 0.001
 PH 7.42 ± 0.10 7.40 ± 0.11 7.38 ± 0.13 0.230
 PaO2 (mmHg) 78.9 (56.7–114.0) 77.3 (61.6–92.0) 71.0 (56.0–89.0) 0.631
 PaCO2 (mmHg) 38.7 (33.4–45.2) 33.6 (32.0–55.2) 41.0 (35.0–47.0) 0.622
 Oxygenation index (mmHg) 205.0 (86.0–280.0) 150.0 (62.0–188.0) 87.0 (66.0–166.0) 0.011
 Proteinuria 13 (22.0) 9 (81.8) 24 (64.9) <0.001
 Hematuria 19 (32.2) 7 (63.6) 21 (56.8) 0.023
Kidney function
 Baseline Scr (μmol/L) 58 (48–66) 58 (54–72) 72.0 (65.0–80.5) <0.001
 Scr on ICU admission (μmol/L) 56.8 (48.6–68.8) 78.0 (55.0–95.0) 84.0 (70.0–124.5) <0.001
 Scr at the time of AKI diagnosis (μmol/L) 56.8 (48.6–68.8) 111.4 (95.0–134.2) 131.7 (113.5–164.6) <0.001
 Peak Scr (μmol/L) 67.6 (57.6–77.1) 111.4 (100.0–245.4) 212.5 (136.5–287.5) <0.001
 Oliguria 0 5 (45.5) 12 (32.4) <0.001
AKI stage <0.001
 1 0 6 (54.5) 11 (29.7)
 2 0 1 (9.1) 8 (21.6)
 3 0 4 (36.4) 18 (48.6)

Notes: Values are n (%), mean ± SD, or median (interquartile range). Abbreviations: AKI: acute kidney injury; COPD: chronic obstructive pulmonary disease; CKD: chronic kidney disease; MAP: mean arterial pressure; 1 mmHg = 0.133 kPa. Scr: serum creatinine; BUN: blood urea nitrogen; ICU: intensive care unit. aP values represent the comparability across the three groups.